Search

Displaying results 2761 - 2770 of 8010 in total

Drug
Flumethasone
go.drugbank.com/drugs/DB00663
ApprovedVet approved
As it is a privalate salt, its anti-inflammatory action is concentrated at the site of application.
Drug
Bentiromide
go.drugbank.com/drugs/DB00522
ApprovedWithdrawn
Bentiromide is a dipeptide that is used in the bentiromide test, which is a screening test for evaluating pancreatic exocrine function and monitoring the adequacy of supplemental pancreatic therapy. … Bentiromide is currently not available in the U.S. or Canada.
Categories: Tests for Pancreatic Function, Compounds used in a research, industrial, or household setting
Drug
Finafloxacin
go.drugbank.com/drugs/DB09047
ApprovedWithdrawn
Finafloxacin is marketed by Novartis under the brand Xtoro™, and was approved by the FDA in December 2014. … Finafloxacin is a fluoroquinolone antibiotic indicated in the treatment of acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.
Drug
Pantethine
go.drugbank.com/drugs/DB11190
Approved
It consists of two molecules of pantetheine that form a dimer via disufide linkages, and acts as an intermediate in the production of Coenzyme A. … Pantethine is available as a dietary supplement for lowering blood cholesterol and triglycerides.
Drug
Guanfacine
go.drugbank.com/drugs/DB01018
ApprovedInvestigational
Guanfacine, or BS 100-141,[A189838,A189841] is a selective alpha-A2 adrenergic receptor agonist initially indicated for the treatment of hypertension[L11274] but is now indicated as an extended release … tablet for the treatment of ADHD.
Categories: Antihypertensive Agents Indicated for Hypertension
Drug
Ceruletide
go.drugbank.com/drugs/DB00403
Approved
Caerulein is a specific decapeptide similar in action and composition to the natural gastrointestinal peptide hormone cholecystokinin. It exerts stimulatory effects on the gastric, biliary, and pancreatic secretion, as well as on certain...
Categories: Tests for Bile Duct Patency
Drug
Meclofenamic acid
go.drugbank.com/drugs/DB00939
ApprovedInvestigationalVet approved
A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
Categories: Topical Products for Joint and Muscular Pain, Antiinflammatory Preparations, Non-Steroids for Topical Use
Drug
Nalbuphine
go.drugbank.com/drugs/DB00844
ApprovedInvestigational
It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors.
Categories: Heterocyclic Compounds with 4 or More Rings
Drug
Lazertinib
go.drugbank.com/drugs/DB16216
ApprovedInvestigational
[A264289] It was approved by the FDA on August 19, 2024.[L51189] Lazertinib is used alone or in combination with other chemotherapeutic agents.[L51184] … [A264299, A264304] Lazertinib was first approved in South Korea on January 18, 2021, for the treatment of _EGFR_ T790M mutation-positive non-small cell lung cancer (NSCLC) with EGFR mutations.
Drug
Ambrisentan
go.drugbank.com/drugs/DB06403
ApprovedInvestigational
As an endothelin receptor antagonist, Ambrisentan prevents endogenous endothelin peptide from constricting the muscles in blood vessels, allowing them to relax and permit a reduction in blood pressure. … Ambrisentan is an orally active selective type A endothelin receptor antagonist indicated for the treatment of pulmonary arterial hypertension.
Categories: Antihypertensives for Pulmonary Arterial Hypertension